Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

The stock is extremely overbought (RSI ~80, Stoch >90), far above the 50-week (~$68) and 100-day (~$50) moving averages, and ...

GD trades at 21x earnings on $54 billion in revenue, yet commands nearly the same market cap as unprofitable RKLB at 115x sales. General Dynamics returned over $2 billion to shareholders through ...

VentureBeat surveyed 132 enterprise AI leaders: the production failure point isn't the model — it's the runtime layer most ...

Rocket Lab Corporation has significantly outperformed since my last update, getting the plaudits amid renewed space stock ...

Logitech's Jay Lyons explains how the shift from passive learning to active creation is reshaping higher education AV design.

Rocket Lab (RKLB) sits at the center of several recent shifts, with new FCC satellite spectrum rules, a record quarter, fresh defense contracts and a delayed Neutron rocket timeline all shaping how ...

Report using research from senior Blair and Clinton pollster comes as Labour braces for dismal election results ...

Amazon has a nearly bottomless supply of doodads and knick knacks, including a sea of cheap, useless stuff, but if you look ...

Lam Research is expanding into panel-level chip packaging with a new research lab in Salzburg, Austria. The lab focuses on ...

The restaurants we loved in the 2000s feel quaint compared to today's convenience-first DoorDash dining trend. These ...

Rezdiffra leads MASH as TAM expands; growth for 2–3 years but big competition risks. Click for more on MDGL here.